Invests in
Sectors:
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
- TU
- Uo
- I
Lists including Michael
Work Experience
2024
Member Board of Directors
2024
2023
Guest to the Board
2023
2021
Member Board of Directors
2021
2020
Partner
2023
Venture Partner
2020 - 2023
2006 - 2020
SVP Head of Operations R&D & Copenhagen Site Manager
2018 - 2020
SVP Clinical Development & Copenhagen Site Manager
2010 - 2017
SVP Clinical Development
2010 - 2010
VP, Head of Development Project Management
2009 - 2010
VP - US Development Operations
2008 - 2008
Director - Project Management
2006 - 2008
Overall responsibility for two of Genmab,s Development projects
2005 - 2006
Associate
2005 - 2006
- Evaluation of clinical trial protocols and resulting data from BankInvest’s portfolio companies - Overview of established therapies per therapeutic area & market potential - Gold standards, medical need, treatment cost, market up-take - Project portfolio valuation of BankInvest’s portfolio companies; based on DCF/NPV calculations - Due Diligence in connection with new and follow-on investments; technology, clinical data, patents - Generation and implementation of re-structuring plans for one of BankInvest’s portfolio companies - Overview of Biotech / Pharma Industry landscape - M & A, licensing deals, therapeutic areas, product pipeline, development stage, clinical data
1998 - 2005
Associate - Scientific Licensing
2004 - 2005
- Identification and evaluation of new licensing opportunities within cancer inflammation - Leading of cross-functional evaluation teams - Science, strategic fit, IPR, market potential - Presenting results and recommendation to Discovery Management - Establishment of: - Strategic and collaborative alliances - In- and out licensing agreements - Agreements – Research, Consultancy and Material transfer - Participation in Discovery’s alliance implementation and management - Focus on contractual and relationship issues - Maintenance of agreements
Pharmacologist
1998 - 2005
- Design, implementation and evaluation of in vivo pharmacological studies to drive progress of discovery and early development projects - Establishment of state of the art disease models: - 1 year+ inflammation and cancer - 2 years+: obesity and type 2 diabetes - 2 years+: Growth Hormone physiology and reproduction - Initiation and monitoring of contract research projects - Scientific reporting internally and externally - Supervision and performance appraisal of reporting technical staff
1992 - 1998
Research Fellow & Associate Principle Scientist (RCDMB)
1996 - 1998
Post Doc at Research Centre for Developmental Medicine & Biology (RCDMB)
1992 - 1996